Study to Determine Racial and Gender Differences in Platelet Aggregation

The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Platelet Aggregation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

TTUHSC

Lubbock, Texas, 79430, United States

About this study

Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking.

We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Race of Caucasian, African American, or Hispanic

Exclusion criteria

Chronic medical conditions
Tobacco use
Regular non-steroidal anti-inflammatory use, aspirin use, or use of one of the other anti-platelet drugs.

Treatment and study plan

Blood draw

Procedure

Sponsors and collaborators

Lead sponsor

Texas Tech University Health Sciences Center

Other

Registry information

Official study title

Phase 1 Study to Determine Racial and Gender Differences in Platelet Aggregation

Important dates

Study start: 2005
Primary completion: 2006
Study completion: 2006
First posted: Oct 5, 2005
Registry last updated: May 12, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed